CN107064516B - 用于诊断中风的nt-原anp和nt-原bnp - Google Patents
用于诊断中风的nt-原anp和nt-原bnp Download PDFInfo
- Publication number
- CN107064516B CN107064516B CN201610812599.8A CN201610812599A CN107064516B CN 107064516 B CN107064516 B CN 107064516B CN 201610812599 A CN201610812599 A CN 201610812599A CN 107064516 B CN107064516 B CN 107064516B
- Authority
- CN
- China
- Prior art keywords
- subject
- sample
- proanp
- amount
- acute cerebral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/575—Hormones
- G01N2333/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Brain natriuretic peptide [BNP, proBNP]; Cardionatrin; Cardiodilatin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2871—Cerebrovascular disorders, e.g. stroke, cerebral infarct, cerebral haemorrhage, transient ischemic event
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/50—Determining the risk of developing a disease
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Endocrinology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11191579.9 | 2011-12-01 | ||
| EP11191579 | 2011-12-01 | ||
| CN201280068882.4A CN104094121B (zh) | 2011-12-01 | 2012-11-29 | 用于诊断中风的nt-原anp和nt-原bnp |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201280068882.4A Division CN104094121B (zh) | 2011-12-01 | 2012-11-29 | 用于诊断中风的nt-原anp和nt-原bnp |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN107064516A CN107064516A (zh) | 2017-08-18 |
| CN107064516B true CN107064516B (zh) | 2019-08-02 |
Family
ID=47278813
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610812599.8A Active CN107064516B (zh) | 2011-12-01 | 2012-11-29 | 用于诊断中风的nt-原anp和nt-原bnp |
| CN201280068882.4A Active CN104094121B (zh) | 2011-12-01 | 2012-11-29 | 用于诊断中风的nt-原anp和nt-原bnp |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201280068882.4A Active CN104094121B (zh) | 2011-12-01 | 2012-11-29 | 用于诊断中风的nt-原anp和nt-原bnp |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US10732188B2 (enExample) |
| EP (2) | EP3290924B1 (enExample) |
| JP (2) | JP6059735B2 (enExample) |
| CN (2) | CN107064516B (enExample) |
| CA (2) | CA2856461C (enExample) |
| ES (2) | ES2899923T3 (enExample) |
| WO (1) | WO2013079567A2 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016056664A1 (ja) * | 2014-10-10 | 2016-04-14 | 松森 昭 | 心不全患者の検出方法、心疾患の識別方法、心不全の検査試薬、心不全の検査キット、心不全を検出するための装置及び心不全を検出するためのプログラム |
| BR112021001798A2 (pt) * | 2018-07-31 | 2021-04-27 | F. Hoffmann-La Roche Ag | métodos para avaliar a fibrilação atrial, para diagnosticar insuficiência cardíaca, para auxiliar na avaliação da fibrilação atrial, para prever o risco de acidente vascular cerebral e para aprimorar a precisão da previsão, usos e kit |
| US11931207B2 (en) | 2018-12-11 | 2024-03-19 | Eko.Ai Pte. Ltd. | Artificial intelligence (AI) recognition of echocardiogram images to enhance a mobile ultrasound device |
| US11446009B2 (en) | 2018-12-11 | 2022-09-20 | Eko.Ai Pte. Ltd. | Clinical workflow to diagnose heart disease based on cardiac biomarker measurements and AI recognition of 2D and doppler modality echocardiogram images |
| US12322100B2 (en) | 2018-12-11 | 2025-06-03 | Eko.Ai Pte. Ltd. | Automatic clinical workflow that recognizes and analyzes 2D and doppler modality echocardiogram images for automated cardiac measurements and grading of aortic stenosis severity |
| US12400762B2 (en) | 2018-12-11 | 2025-08-26 | Eko.Ai Pte. Ltd. | Automatic clinical workflow that recognizes and analyzes 2D and doppler modality echocardiogram images for automated cardiac measurements and diagnosis of cardiac amyloidosis and hypertrophic cardiomyopathy |
| US12001939B2 (en) | 2018-12-11 | 2024-06-04 | Eko.Ai Pte. Ltd. | Artificial intelligence (AI)-based guidance for an ultrasound device to improve capture of echo image views |
| JP7698310B2 (ja) * | 2019-05-16 | 2025-06-25 | フンダシオ オスピタル ウニベルシタリ バル デブロン－インスティテュート デ レセルカ | 再灌流療法のために患者を選択する方法 |
| JP2021173559A (ja) | 2020-04-21 | 2021-11-01 | 株式会社デンソー | 物理量計測装置 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5744101A (en) | 1989-06-07 | 1998-04-28 | Affymax Technologies N.V. | Photolabile nucleoside protecting groups |
| GB9211686D0 (en) | 1992-06-03 | 1992-07-15 | Medisinsk Innovation A S | Chemical compounds |
| WO2003016910A1 (en) | 2001-08-20 | 2003-02-27 | Biosite, Inc. | Diagnostic markers of stroke and cerebral injury and methods of use thereof |
| US7632647B2 (en) | 2001-04-13 | 2009-12-15 | Biosite Incorporated | Use of B-type natriuretic peptide as a prognostic indicator in acute coronary syndromes |
| DE60233301D1 (de) | 2001-05-04 | 2009-09-24 | Biosite Inc | Diagnostische marker für akute herzerkrankungen und verfahren des gebrauchs |
| WO2004059293A2 (en) * | 2002-12-24 | 2004-07-15 | Biosite Incorporated | Markers for differential diagnosis and methods of use thereof |
| US7517951B2 (en) * | 2002-12-24 | 2009-04-14 | Nitto Boseki Co., Ltd. | Marker proteins for diagnosing liver disease and method of diagnosing liver disease using the same |
| US20050181386A1 (en) * | 2003-09-23 | 2005-08-18 | Cornelius Diamond | Diagnostic markers of cardiovascular illness and methods of use thereof |
| EP1582597A1 (en) | 2004-03-29 | 2005-10-05 | Aventis Pharma Deutschland GmbH | Method of diagnosis of a predisposition to develop thrombotic disease and its uses |
| US20060166303A1 (en) * | 2005-01-24 | 2006-07-27 | Eberhard Spanuth | Use of cardiac hormones for assessing a cardiovascular risk with respect to the administration of anti-inflammatory drugs |
| WO2006077265A1 (en) | 2005-01-24 | 2006-07-27 | F. Hoffmann-La Roche Ag | The use of bnp-type peptides and anp-type peptides for assessing the risk of suffering from a cardiovascular complication as a consequence of volume overload |
| JP4828550B2 (ja) * | 2005-02-17 | 2011-11-30 | エフ．ホフマン−ラ ロシュ アーゲー | 心機能障害を診断するためのＮＴ−ｐｒｏＡＮＰ／ＮＴ−ｐｒｏＢＮＰ比の使用 |
| EP1731910A1 (en) * | 2005-06-07 | 2006-12-13 | F. Hoffmann-La Roche Ag | Use of NT-proANP and NT-proBNP for diagnosing cardiac diseases |
| DE102005048899A1 (de) * | 2005-10-12 | 2007-04-19 | Sanofi-Aventis Deutschland Gmbh | Verfahren zur Diagnose thromboembolischer Erkrankungen und koronarer Herzerkrankungen |
| DE602006014798D1 (de) | 2006-03-24 | 2010-07-22 | Roche Diagnostics Gmbh | Vorrichtung und Verfahren zur Unterscheidung zwischen akuter und chronischer Myokardial-Nekrose bei symptomatischen Patienten |
| EP1882945A1 (en) * | 2006-07-28 | 2008-01-30 | F.Hoffmann-La Roche Ag | Means and methods for the differentiation of cardiac and pulmonary causes of acute shortness of breath |
| DE602006010705D1 (de) * | 2006-09-15 | 2010-01-07 | Roche Diagnostics Gmbh | Biochemische Marker für akute Lungenembolie |
| WO2009047285A1 (en) | 2007-10-10 | 2009-04-16 | Roche Diagnostics Gmbh | Natriuretic peptide/troponin ratio for the assessment of preexisting myocardial dysfunction in patients with acute coronary syndrome |
| EP2356450B1 (en) * | 2008-10-24 | 2019-02-06 | B.R.A.H.M.S GmbH | Prognosis and risk assessment in stroke patients by determining the level of marker peptides |
| AU2009339152B2 (en) * | 2009-01-30 | 2015-11-19 | Bio-Rad Europe Gmbh | Method for the in vitro diagnosis of stroke |
| EP2466311A1 (en) | 2010-12-17 | 2012-06-20 | Roche Diagnostics GmbH | sFlt1 in patients with ischemic stroke |
-
2012
- 2012-11-29 CA CA2856461A patent/CA2856461C/en active Active
- 2012-11-29 CA CA3081979A patent/CA3081979C/en active Active
- 2012-11-29 JP JP2014543882A patent/JP6059735B2/ja active Active
- 2012-11-29 EP EP17196637.7A patent/EP3290924B1/en active Active
- 2012-11-29 WO PCT/EP2012/073897 patent/WO2013079567A2/en not_active Ceased
- 2012-11-29 ES ES17196637T patent/ES2899923T3/es active Active
- 2012-11-29 CN CN201610812599.8A patent/CN107064516B/zh active Active
- 2012-11-29 EP EP12794941.0A patent/EP2786154B1/en active Active
- 2012-11-29 CN CN201280068882.4A patent/CN104094121B/zh active Active
- 2012-11-29 ES ES12794941.0T patent/ES2656082T3/es active Active
-
2014
- 2014-05-30 US US14/291,676 patent/US10732188B2/en active Active
-
2016
- 2016-12-09 JP JP2016239317A patent/JP6441885B2/ja active Active
-
2020
- 2020-06-30 US US16/916,809 patent/US20200333360A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CN104094121A (zh) | 2014-10-08 |
| CA3081979A1 (en) | 2013-06-06 |
| EP2786154B1 (en) | 2017-11-01 |
| HK1201327A1 (en) | 2015-08-28 |
| CN104094121B (zh) | 2016-10-26 |
| JP6059735B2 (ja) | 2017-01-11 |
| US20200333360A1 (en) | 2020-10-22 |
| WO2013079567A3 (en) | 2013-08-29 |
| WO2013079567A2 (en) | 2013-06-06 |
| EP2786154A2 (en) | 2014-10-08 |
| US20140274793A1 (en) | 2014-09-18 |
| EP3290924B1 (en) | 2021-10-13 |
| JP6441885B2 (ja) | 2018-12-19 |
| CN107064516A (zh) | 2017-08-18 |
| EP3290924A1 (en) | 2018-03-07 |
| ES2899923T3 (es) | 2022-03-15 |
| US10732188B2 (en) | 2020-08-04 |
| ES2656082T3 (es) | 2018-02-23 |
| JP2017075959A (ja) | 2017-04-20 |
| JP2015504519A (ja) | 2015-02-12 |
| CA3081979C (en) | 2023-07-11 |
| CA2856461A1 (en) | 2013-06-06 |
| CA2856461C (en) | 2020-08-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN107064516B (zh) | 用于诊断中风的nt-原anp和nt-原bnp | |
| CN104769436B (zh) | 阵发性心房纤颤的基于TnT的诊断 | |
| US11047865B2 (en) | Troponin and BNP based diagnosis of risk patients and cause of stroke | |
| JP2020034564A (ja) | 心不全リスクの予測改善のためのバイオマーカー | |
| JP2013527453A (ja) | 急性炎症における生存および回復を推定するためのｇｄｆ−１５に基づく手段および方法 | |
| HK1241021B (zh) | 用於诊断中风的nt-原anp和nt-原bnp | |
| HK1241021A1 (en) | Nt-proanp and nt-probnp for the diagnosis of stroke | |
| HK1201327B (en) | Nt-proanp and nt-probnp for the diagnosis of stroke | |
| HK1212434B (en) | Tnt based diagnosis of paroxysmal atrial fibrillation | |
| HK1224745A1 (en) | Troponin and bnp based diagnosis of risk patients and cause of stroke | |
| HK1196158B (en) | Troponin and bnp based diagnosis of risk patients and cause of stroke | |
| HK1224745B (zh) | 风险患者和中风原因的基於肌钙蛋白和bnp的诊断 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1241021 Country of ref document: HK |
|
| GR01 | Patent grant | ||
| GR01 | Patent grant |